FINDER FEE AGREEMENTFinder's Fee Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
This agreement (the “Agreement”) is made as of this 7th day of April, 2005, by and between Glenrock Israel Ltd. of 85 Medinat Hayehudim St. Tower G, 8th Floor, Herzliya Pituach, Israel (the “Finder”); and Rosetta Genomics Ltd. of 10 Plaut Street, Jerusalem, Israel, (the “Company”).
LICENSE AGREEMENTLicense Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
At the Max-Planck-Institute for Biophysical Chemistry in Goettingen, an institute of the Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (hereinafter “MPG“), a German non-profit scientific research organisation, Dr. Thomas Tuschl and other scientists of MPG have discovered certain microRNA sequences (internal GI file No. GI 2916 ZJE). MPG has filed certain MPG Patent Rights (as later defined herein) relating thereto.
EXCLUSIVE LICENSE AGREEMENT BETWEEN THE JOHNS HOPKINS UNIVERSITY ROSETTA GENOMICS LTD JHU Ref: # - 4950Exclusive License Agreement • September 1st, 2006 • Rosetta Genomics Ltd. • Maryland
THIS LICENSE AGREEMENT (the “Agreement”) is entered into by and between THE JOHNS HOPKINS UNIVERSITY, a Maryland corporation having an address at 3400 N. Charles Street, Baltimore, Maryland, 21218-2695 (“JHU”) and Rosetta Genomics Ltd., an Israeli corporation having an address at 10 Plaut St. Rehovot (“Company”), with respect to the following:
LICENSE AGREEMENT (the “Agreement”)License Agreement • September 1st, 2006 • Rosetta Genomics Ltd. • New York
Ambion, Inc., a Delaware corporation having its principal office at 2130 Woodward St., Austin, Texas 78744, hereinafter “AMBION”. AMBION and ROSETTA may be referred to individually as the “Party” or collectively as the “Parties”.
RESEARCH AND LICENSE AGREEMENT (HVC)Research and License Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
This agreement (the "Agreement") is made and entered into as of the 30 day of May, 2005 (the "Effective Date") by and between Rosetta Genomics Ltd., a private company registered under the laws of the State of Israel, of 10 Plaut Street, Science Park, Rehovot, Israel ("Rosetta") and Hadasit Medical Research Services and Development Ltd., a private company registered under the laws of the state of Israel, of Hadassah Medical Hospital, POB 12000, Jerusalem, Israel ("Hadasit").
The Rockefeller University License AgreementLicense Agreement • September 1st, 2006 • Rosetta Genomics Ltd. • New York
This Agreement (this “Agreement”) is between The Rockefeller University, a New York nonprofit corporation (“Rockefeller”), and Rosetta Genomics Ltd., an Israeli corporation (“Company”). This Agreement will become effective on May 4, 2006 (the “Effective Date”).
Research Collaboration AgreementResearch Collaboration Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
This agreement (this “Agreement”) is made and entered into as of the 22 day of June, 2006 (the “Effective Date”) by and between Rosetta Genomics Ltd., a private company registered pursuant to the laws of the State of Israel, of 10 Plaut Street, Science Park, Rehovot, Israel (“Rosetta”) and Hadasit Medical Research Services and Development Ltd., a private company registered under the laws of the state of Israel, of Hadassah Medical Hospital, POB 12000, Jerusalem, Israel (“Hadasit”).
RESEARCH COLLABORATION AGREEMENTResearch Collaboration Agreement • September 1st, 2006 • Rosetta Genomics Ltd. • Delaware
THIS RESEARCH COLLABORATION AGREEMENT (this “Agreement”) is made and entered into effective as of January 31, 2006 (the “Effective Date”), by and between Rosetta Genomics, Ltd., a private company registered under the laws of the State of Israel (“Rosetta”), and Isis Pharmaceuticals, Inc., a Delaware corporation (“Isis”). Rosetta and Isis each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
May 8, 2002 To: Mr. Yossi Ben-Yossef Kadima Hi-Tech Re: Investment in our companyInvestment Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
We are hereby to put in writing our agreement in respect of investment to be made by a group in investors handled by you, and / or other investors handled by you.
License Agreement Made as of the 23 day of June 2003 (the “Effective Date”)License Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
By and between Maimonides Innovative Technologies Ltd. (“Maimonides”), of the first part, and Rosetta Genomics Ltd (“Rosetta”), of the second part.
Research Collaboration AgreementResearch Collaboration Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
This agreement (this “Agreement”) is made and entered into as of the 16th day of May 2006 (the “Effective Date”) by and between Rosetta Genomics Ltd., a private company registered pursuant to the laws of the State of Israel, of 10 Plant Street, Science Park, Rehovot, Israel (“Rosetta”) and Tel Hashomer Medical Research Infrastructure and Services Ltd. a company duly registered under the laws of the state of israel (hereinafter: “THM”), located at Tel Hahsomer, 52621 Israel established pursuant to the laws of the State Of Israel (“THM”).
COLLABORATION AND LICENSE AGREEMENT by and between ROSETTA GENOMICS, LTD. and AMBION DIAGNOSTICS, INC. January 5, 2006Collaboration and License Agreement • September 1st, 2006 • Rosetta Genomics Ltd. • York
This COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of January 5, 2006, by and between Rosetta Genomics, Ltd., a corporation organized under the country of Israel having an address of 10 Plaut Street, Science Park, Rehovot, Israel (“ROSETTA”) and Ambion Diagnostics, Inc., a Delaware corporation having an address of 2130 Woodward St., Austin, Texas 78744 (“AMBION”). Each of AMBION and ROSETTA is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
MADAI'IM 1 Contract of Lease Made and Entered into in Rehovot on the 4th August 2003Contract of Lease • September 1st, 2006 • Rosetta Genomics Ltd.
The Lessee undertakes to obtain all the permits and licenses required for the purpose of the operating of the Property for the above stated purpose in its name and to operate the business managed in the Property pursuant to the terms and conditions of the permits and licenses and subject to the provisions of any law.
COLLABORATION AND LICENSE AGREEMENT by and between ROSETTA GENOMICS, LTD. and US GENOMICS, INC. May 12, 2006Collaboration and License Agreement • September 1st, 2006 • Rosetta Genomics Ltd. • New York
This COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of May 12, 2006, by and between Rosetta Genomics, Ltd., a corporation organized under the country of Israel having an address of 10 Plaut Street, Science Park, Rehovot, Israel (“Rosetta Genomics”) and US Genomics, Inc., a Delaware corporation having an address of 12 Gill Street. Suite 4700, Woburn, MA 01801 (“US Genomics”). Each of US Genomics and Rosetta Genomics is sometimes referred to individually herein as a “Party” and collectively as the “Parties.”
TECHNOLOGY CENTRE OF NEW JERSEY COMMERCIALIZATION CENTER FOR INNOVATIVE TECHNOLOGIES LEASE AGREEMENTLease Agreement • September 1st, 2006 • Rosetta Genomics Ltd. • New Jersey
AGREEMENT OF LEASE made the 15 day of March, 2006, by and between THE NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY hereinafter referred to as “LANDLORD”, and, Rosetta Genomics,Inc. a New Jersey corporation, hereinafter referred to as “TENANT”.
FINDER FEE AGREEMENTFinder's Fee Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
This agreement (the "Agreement") is made as of this 8th day of September, 2004, by and between Glenrock Israel Ltd. of 85 Medinat Hayehudim St. Tower G, 8th Floor, Herzliya Pituach, Israel (the“Finder”); and Rosetta Genomics Ltd. of 10 Plaut Street, Jerusalem, Israel, (the “Company").
FINDER FEE AGREEMENTFinder's Fee Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
This agreement (the “Agreement”) is made as of this 22 day of March, 2006, by and between Rosenram Business Development Ltd. of 52 Menachem Begin Road, Tel Aviv (the “Finder”); and Rosetta Genomics Ltd. of 10 Plant Street, Jerusalem, Israel, (the “Company”).
Rosetta Genomics Ltd. August 15, 2004Consulting Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
We are pleased to have the opportunity to render Glenrock's services as consultants of Rosetta (Genomics Ltd (the "Company"). We expect that Glenrock's contribution as consultants of the Company will be of significant strategic benefit to the Company in establishing its business and developing its technologies.
AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENTInvestors Rights Agreement • September 1st, 2006 • Rosetta Genomics Ltd.
WHEREAS the Board of Directors of the Company has determined that it is in the best interest of the Company that the Company shall grant the Preferred Shareholders, the Founding Shareholders and the Ordinary Shareholders (together, the "Shareholders") certain rights as set forth herein; and
